Get started
NeoGenomics, Inc.
Long

NeoGenomics stock is soaring?

22
NeoGenomics stock is soaring? A federal court just invalidated Natera's patent claims, freeing NEO to commercialize its RaDaR ST cancer test. This is a huge win, potentially unlocking massive growth. #NeoGenomics #Stocks #Biotech #PatentLaw
Mahdi_Asgari
Also on:
Chart PatternsFundamental Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Chart PatternsFundamental Analysis
Mahdi_Asgari
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.